| dc.contributor | Corona-Rivera, A., Laboratorio de Citogenética Genotoxicidad y Biomonitoreo, Instituto de Genética Humana Dr. Enrique Corona Rivera, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, Unidad de Citogenética, OPD Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico, Laboratorio de Genética Humana, Departamento de Fisiología, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Salamanca-Gomez, F., Unit of Investigation in Human Genetics, National Medical Center, Instituto Mexicano del Seguro Social, México City, Mexico; Bobadilla-Morales, L., Laboratorio de Citogenética Genotoxicidad y Biomonitoreo, Instituto de Genética Humana Dr. Enrique Corona Rivera, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, Laboratorio de Genética Humana, Departamento de Fisiología, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Corona-Rivera, J.R., Laboratorio de Citogenética Genotoxicidad y Biomonitoreo, Instituto de Genética Humana Dr. Enrique Corona Rivera, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, División de Pediatría, OPD Hospital Civil Juan I. Menchaca, Guadalajara, Jalisco, Mexico, Laboratorio de Genética Humana, Departamento de Fisiología, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Palomino-Cueva, C., Laboratorio de Genética Humana, Departamento de Fisiología, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Garcia-Cobian, T.A., Laboratorio de Genética Humana, Departamento de Fisiología, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Corona-Rivera, E., Laboratorio de Genética Humana, Departamento de Fisiología, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico | |
| dc.description.abstract | Background: Mitotic configurations consistent in split centromeres and splayed chromatids in all or most of the chromosomes or premature centromere division (PCD) have been described in three categories. (1) Low frequency of PCD observed in colchicines-treated lymphocyte cultures from normal individuals. (2) High frequency of PCD with mosaic variegated aneuploidy. (3) High frequency of PCD as a sole chromosome abnormality observed in individuals with no recognizable clinical pattern. We report four members of a family with the third category of PCD. Methods: Cell cycle duration assessed by average generation time using differential sister chromatid stain analysis and FISH studies of DNA centromere sequences in PCD individuals, are included and compared with previously reported PCD individuals from 9 families. Results: We observed PCD in colchicine-treated cultures from the propositus, his father, and two paternal aunts but not in his mother and four other paternal and maternal family members, as well as in untreated cultures from the propositus and his father. We observed cytological evidence of active centromeres by Cd stain. Significative cell cycle time reduction in anaphases of PCD individuals (average generation time of 21.8h;SD 0.4) with respect to individuals without PCD (average generation time of 31.8h;SD 3.9) was observed (P<0.005, Student t-test for independent samples). Increased cell proliferation kinetics was observed in anaphasic cells of individuals with PCD, by differential sister chromatid stain analysis. FISH studies revealed the presence of alpha satellite DNA from chromosomes 1, 13, 21/18, X, all centromeres, and CENP-B box sequences in metaphasic and anaphasic cells from PCD individuals. Conclusions: This report examines evidences of a functional relationship between PCD and cell cycle impairment. It seems that essential centromere integrity is present in these cases. © 2005 Corona-Rivera et al., licensee BioMed Central Ltd. | |
